title: The research agenda in VAP/HAP: next steps.
authors.affiliation: Division of Pulmonary and Critical Care Medicine, New York Presbyterian/Weill Cornell Medical Center, 425 E. 61st St, 4th Floor, New York, NY, 10065, USA. msn9004@med.cornell.edu.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Niederman
authors.affiliation: Intensive Care Medicine, Department of Clinical Medicine, St. James's University Hospital, Trinity Centre for Health Sciences, Dublin, Ireland.
authors.forename: Ignacio
authors.initials: I
authors.lastname: Martin-Loeches
authors.affiliation: Pulmonary Intensive Care Unit, Respiratory Institute, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
authors.forename: Antoni
authors.initials: A
authors.lastname: Torres
mesh_terms: D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003428:Cross Infection / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D018432:Drug Resistance, Multiple; D005060:Europe; D006801:Humans; D007362:Intensive Care Units; D017063:Outcome Assessment, Health Care; D011014:Pneumonia / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D053717:Pneumonia, Ventilator-Associated / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D012121:Respiration, Artificial / Q000009:adverse effects; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents
keywords: Initial Empiric Antibiotic Therapy; Live Microbial Cell; Nebulized Antibiotic; Nosocomial Respiratory Infection; Rapid Diagnostic Method